The second phase of SpikoGen clinical trial started, Jahanpour wrote in his Twitter account on Tuesday.
He added that the first phase were done in Australia.
During the second phase, the vaccine will be injected to 400 candidates, he added.
An Iranian pharmaceutical company is to produce the vaccine jointly with an Australian firm.